Bland and Copeland's The Breast

Creating a Breast Cancer Survivorship Plan and Clinic

Background As of January 2019, there were 16.9 million cancer survivors in the United States, of which women with a history of breast cancer made up 3.8 million (22.5%). Breast cancer remains the most common cancer affecting women, with greater…

Unknown Primary Presenting With Axillary Lymphadenopathy

Breast cancer can rarely present as isolated axillary adenopathy without any evidence of a primary breast mass, creating many diagnostic and therapeutic challenges. Occult breast cancer is defined as isolated axillary adenocarcinoma without detectable tumor in the breast by either…

Carcinoma of the Breast in Pregnancy and Lactation

Pregnancy-associated breast cancer (PABC) is often defined as breast cancer during pregnancy or within 1 year postpartum. Outcomes first reported in the early decades of the 20th Century were dismal. In 1929 Kilgore and Bloodgood reported a 16% (n =…

Male Breast Cancer

Epidemiology Male breast cancer (MBC) is a rare diagnosis, with approximately 2650 estimated cases and 530 deaths in the United States in 2021. MBC accounts for less than 1% of all breast cancers and less than 0.2% of all male…

Bilateral Breast Cancer

In 1945 Foote and Stewart memorably stated that “the most frequent antecedent of cancer of one breast is the history of having had cancer in the opposite breast,” and contralateral breast cancer (CBC) remains the most frequent second-cancer event, historically…

Immunological Approaches to Breast Cancer Therapy

Principles of Breast Cancer Immunotherapy Immunology of Breast Cancer The association of breast tumor immune cell (IC) infiltration and prognosis has been appreciated for decades. Given the correlation between tumor infiltrating lymphocytes (TILs), treatment response, and outcome, guidelines have been…